Context Therapeutics Inc.

CNTX · NASDAQ
Analyze with AI
$1.14+$0.095 (+9.13%)
At close:Dec 15, 2025, 8:59 PM UTC
$1.11−$0.025 (−2.2%)
After hours:Dec 15, 2025, 10:10 PM UTC
P/E TTM-3.16
P/B TTM1.31
P/S TTM0
Dividend Yield0%
EPS-$0.24
Beta1.941
Valuation
PEG Ratio0.23
FCF Yield-20.74%
EV / EBITDA-0.56
Quality
ROIC-46.30%
Gross Margin0.00%
Cash Conv. Ratio0.20
Growth
Revenue 3Y CAGR
FCF Growth-39.27%
Safety
Net Debt / EBITDA2.23
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-215,128.22

Context Therapeutics Inc. (CNTX) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Context Therapeutics Inc. (CNTX) stock price today?

As of Dec 15, 2025, 8:59 PM UTC, Context Therapeutics Inc. (CNTX) stock is trading at $1.14. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date CNTX stock quotes for informed trading decisions.

What is Context Therapeutics Inc.'s market capitalization?

Context Therapeutics Inc. (CNTX) has a market capitalization of approximately $104.3M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Context Therapeutics Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the CNTX stock price changes.

What is the 52-week range for Context Therapeutics Inc. stock?

Context Therapeutics Inc. (CNTX) stock has traded in a 52-week range of $0.49 — $1.55. The 52-week range shows the highest and lowest prices at which CNTX traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Context Therapeutics Inc. stock price to this range provides context for recent price action.

How much trading volume does Context Therapeutics Inc. stock have?

Context Therapeutics Inc. (CNTX) stock recently traded approximately 1.5M shares. Trading volume indicates market liquidity and investor interest in CNTX. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Context Therapeutics Inc. stock.

Does Context Therapeutics Inc. pay dividends to shareholders?

Yes, Context Therapeutics Inc. (CNTX) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Context Therapeutics Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Context Therapeutics Inc.'s intraday price range?

Today, Context Therapeutics Inc. (CNTX) stock has traded in a range of $1.04 — $1.16. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring CNTX's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Context Therapeutics Inc. stock data?

AlphaPilot sources real-time CNTX stock quotes, fundamental financial data, and historical price charts for Context Therapeutics Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Context Therapeutics Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of CNTX stock performance.